Shanghai's "4 + 7" volume procurement and new deal! The demonstration effect will be released!

[policies and regulations of chinapharma.com] on February 19, Shanghai issued the notice on doing a good job in the pilot work of centralized purchasing and use of drugs organized by the state (hereinafter referred to as the "notice") While introducing a number of measures to ensure the priority use of the selected drugs, Shanghai proposed to appropriately increase the proportion of self-sufficiency for the non selected drugs (source of drug pictures: chinapharma.com) the notice made it clear that for the generic name belonging to the catalogue of drugs for Shanghai basic medical insurance, CO insurance and maternity insurance (2017 version), but the same generic name with the price higher than the selected price did not win the selection of drugs, the gradient price reduction or price limit monkey hanging network shall be carried out in accordance with the principle of "price suitability" The proportion of self payment for "expensive drugs" should be increased appropriately If the insured of Shanghai urban employees' basic medical insurance and urban and rural residents' basic medical insurance use "expensive drugs", the proportion of self payment for drugs should be increased by 10% (basic drugs and drugs paid by class a of medical insurance) or 20% (other drugs) For the anticancer drugs with individual quota, the standard of quota self-sufficiency shall be appropriately increased with reference to the above drugs Those who participate in the city's community medical assistance and poverty alleviation plan shall be implemented by reference If the inpatients use "high priced drugs", they shall be settled according to the new self financing proportion at the time of discharge It is understood that in the "4 + 7" varieties, in addition to flurbiprofen ester, levetiracetam, dexmedetomidine and montelukast, the proportion of self payment increased by 20%, while gefitinib and imatinib adjusted the standard of self payment, the proportion of self payment of other drugs increased by 10% In addition, the notice pointed out that all non-profit medical institutions and designated medical institutions of medical insurance in this city should give priority to purchasing and using the selected drugs, and should not influence the supply and rational use of the selected drugs on the grounds of total cost control, "drug proportion" and the number of basic drug varieties of 100 million yuan For the unselected drugs with guaranteed quality and curative effect and appropriate price, the medical institutions may continue to purchase the selected drugs on the premise of priority purchase, but the quantity shall not exceed the selected drugs If a medical institution purchases drugs of the same type that meet the above conditions but fail to be selected, it shall be deemed to meet the requirements of "one product, two regulations" The notice also strengthened the monitoring of drug use, and pointed out that the city's medical insurance department, health department, drug supervision department, drug administration department and district health administration department should be strengthened The notice also emphasizes the frequency and intensity of supervision and inspection of medical insurance for medical institutions that purchase non selected varieties and similar alternative varieties abnormally, referring to the third-party evaluation system of drug purchase Industry insiders said that it is worth noting that as a core city, Shanghai's "4 + 7" volume procurement policy is bound to play a demonstration effect on other cities For example, from March 1, Tianjin and Chongqing will officially launch the pilot work of Roche national centralized procurement and use Liaoning Province requires Shenyang and Dalian to implement the national centralized procurement results on March 20 In addition, at the "4 + 7" work deployment meeting in Beijing, military hospitals other than public hospitals were also encouraged to use the selected drugs For the price reduction requirements of the unselected varieties, Shanghai negotiation results were directly used in reference to Shanghai According to the analysis of relevant people, although the industry expects that it will take a certain time for the volume procurement to be promoted in a larger scope, there is news recently that Fujian is in internal discussion on following up the "4 + 7" volume procurement The selected products can obtain 60% of the basic procurement volume of Fujian Province, and the whole province can start implementation with April 1.